The carbohydrate-insulin model: a physiological perspective on the obesity pandemic.

dietary carbohydrate endocrinology energy balance glucagon incretins insulin macronutrients obesity scholarly discourse weight loss

Journal

The American journal of clinical nutrition
ISSN: 1938-3207
Titre abrégé: Am J Clin Nutr
Pays: United States
ID NLM: 0376027

Informations de publication

Date de publication:
01 12 2021
Historique:
received: 25 06 2021
accepted: 26 07 2021
pubmed: 14 9 2021
medline: 30 8 2022
entrez: 13 9 2021
Statut: ppublish

Résumé

According to a commonly held view, the obesity pandemic is caused by overconsumption of modern, highly palatable, energy-dense processed foods, exacerbated by a sedentary lifestyle. However, obesity rates remain at historic highs, despite a persistent focus on eating less and moving more, as guided by the energy balance model (EBM). This public health failure may arise from a fundamental limitation of the EBM itself. Conceptualizing obesity as a disorder of energy balance restates a principle of physics without considering the biological mechanisms that promote weight gain. An alternative paradigm, the carbohydrate-insulin model (CIM), proposes a reversal of causal direction. According to the CIM, increasing fat deposition in the body-resulting from the hormonal responses to a high-glycemic-load diet-drives positive energy balance. The CIM provides a conceptual framework with testable hypotheses for how various modifiable factors influence energy balance and fat storage. Rigorous research is needed to compare the validity of these 2 models, which have substantially different implications for obesity management, and to generate new models that best encompass the evidence.

Identifiants

pubmed: 34515299
pii: S0002-9165(22)00517-2
doi: 10.1093/ajcn/nqab270
pmc: PMC8634575
doi:

Substances chimiques

Carbohydrates 0
Dietary Carbohydrates 0
Dietary Fats 0
Insulin 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1873-1885

Subventions

Organisme : NCI NIH HHS
ID : R35 CA197588
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the American Society for Nutrition.

Auteurs

David S Ludwig (DS)

New Balance Foundation Obesity Prevention Center, Boston Children's Hospital, Boston, MA, USA.
Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
Department of Nutrition, Harvard TH Chan School of Public Health, Boston, MA, USA.

Louis J Aronne (LJ)

Comprehensive Weight Control Center, Weill Cornell Medicine, New York, NY, USA.

Arne Astrup (A)

Department of Nutrition, Exercise, and Sports, University of Copenhagen, Copenhagen, Denmark.

Rafael de Cabo (R)

Translational Gerontology Branch, National Institute on Aging, NIH, Baltimore, MD, USA.

Lewis C Cantley (LC)

Department of Medicine, Weill Cornell Medicine, New York, NY, USA.

Mark I Friedman (MI)

Monell Chemical Senses Center, Philadelphia, PA, USA.
Nutrition Science Initiative, San Diego, CA, USA.

Steven B Heymsfield (SB)

Metabolism & Body Composition Laboratory, Pennington Biomedical Research Center, Baton Rouge, LA, USA.

James D Johnson (JD)

Diabetes Research Group, Life Sciences Institute, University of British Columbia, Vancouver, British Columbia, Canada.
Institute for Personalized Therapeutic Nutrition, Vancouver, British Columbia, Canada.

Janet C King (JC)

Department of Nutritional Sciences & Toxicology, University of California Berkeley, Berkeley, CA, USA.

Ronald M Krauss (RM)

Department of Pediatrics, University of California San Francisco, San Francisco, CA, USA.
Department of Medicine, University of California San Francisco, San Francisco, CA, USA.

Daniel E Lieberman (DE)

Department of Human Evolutionary Biology, Harvard University, Cambridge, MA, USA.

Gary Taubes (G)

Nutrition Science Initiative, San Diego, CA, USA.

Jeff S Volek (JS)

Department of Human Sciences, Ohio State University, Columbus, OH, USA.

Eric C Westman (EC)

Department of Medicine, Duke University School of Medicine, Durham, NC, USA.

Walter C Willett (WC)

Department of Nutrition, Harvard TH Chan School of Public Health, Boston, MA, USA.
Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA.

William S Yancy (WS)

Department of Medicine, Duke University School of Medicine, Durham, NC, USA.

Cara B Ebbeling (CB)

New Balance Foundation Obesity Prevention Center, Boston Children's Hospital, Boston, MA, USA.
Department of Pediatrics, Harvard Medical School, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH